Robert C. Atkins

Active 1971–2019

89
Papers
22,774
Citations
83
h-index
89
i10-index

Citations

Citations per year for Robert C. Atkins1972: 1 citations1975: 1 citations1976: 2 citations1977: 2 citations1978: 2 citations1979: 2 citations1980: 1 citations1981: 1 citations1982: 1 citations1983: 6 citations1984: 1 citations1985: 3 citations1986: 2 citations1987: 5 citations1988: 7 citations1989: 2 citations1990: 6 citations1991: 12 citations1992: 19 citations1993: 9 citations1994: 27 citations1995: 14 citations1996: 29 citations1997: 36 citations1998: 45 citations1999: 25 citations2000: 67 citations2001: 79 citations2002: 148 citations2003: 287 citations2004: 254 citations2005: 325 citations2006: 221 citations2007: 273 citations2008: 233 citations2009: 225 citations2010: 252 citations2011: 276 citations2012: 204 citations2013: 201 citations2014: 212 citations2015: 169 citations2016: 143 citations2017: 118 citations2018: 129 citations2019: 454 citations2020: 444 citations2021: 381 citations2022: 285 citations2023: 246 citations2024: 333 citations2025: 133 citations2026: 9 citations1973–1974: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,958 citing papers, 23.3% of this breakdownChina: 753 citing papers, 9% of this breakdownAustralia: 743 citing papers, 8.9% of this breakdownUnited Kingdom: 579 citing papers, 6.9% of this breakdownGermany: 403 citing papers, 4.8% of this breakdownItaly: 372 citing papers, 4.4% of this breakdownCanada: 346 citing papers, 4.1% of this breakdownJapan: 340 citing papers, 4.1% of this breakdownNetherlands: 295 citing papers, 3.5% of this breakdownFrance: 226 citing papers, 2.7% of this breakdownSpain: 192 citing papers, 2.3% of this breakdownSouth Korea: 153 citing papers, 1.8% of this breakdown
0%23.3%Other 24.2%

Fields

  • Medicine71.9%
  • Biochemistry, Genetics and Molecular Biology14.2%
  • Immunology and Microbiology7.6%
  • Health Professions2.1%
  • Nursing0.8%
  • Neuroscience0.6%
  • Other2.8%

Topics

  • Chronic Kidney Disease and Diabetes11.6%
  • Dialysis and Renal Disease Management4.6%
  • Blood Pressure and Hypertension Studies4.2%
  • Renal Diseases and Glomerulopathies4%
  • Diabetes Treatment and Management3.8%
  • Advanced Glycation End Products research2%
  • Other69.8%

Coauthors

All papers

Open in search
  1. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

    Authors: , , , , , , , , , - New England Journal of Medicine 2001 cited by 6,001

  2. Cardiovascular Risk Factors Associated With Venous Thromboembolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Beatriz L. Rodríguez, Yoav Ben‐Shlomo, Jean‐Pierre Després, Leon A. Simons, Elizabeth Barrett‐Connor, Cecilia Björkelund, Marlene Notdurfter, Daan Kromhout, Jackie F. Price, Susan E. Sutherland, Johan Sundström, Jussi Kauhanen, John Gallacher, Joline W. J. Beulens, Rachel Dankner, Cyrus Cooper, Simona Giampaoli, Jason F. Deen, Agustı́n Gómez de la Cámara, Lewis H. Kuller, Annika Rosengren, Peter J. Svensson, Dorothea Nagel, Carlos J. Crespo, Hermann Brenner, Juan Rafael Albertorio‐Diaz, Robert C. Atkins, Eric J. Brunner, Martin J. Shipley, Inger Njølstad, Deborah A. Lawlor, Yvonne T. van der Schouw, Randi Selmer, Maurizio Trevisan, W. M. Monique Verschuren, Philip Greenland, Sylvia Wassertheil‐Smoller, Gordon Lowe, Angela Wood, Adam S. Butterworth, Simon G. Thompson, John Danesh, Emanuele Di Angelantonio, Tom Meade - JAMA Cardiology 2019 cited by 362

  3. Macrophage accumulation in human progressive diabetic nephropathy

    Authors: , , , , , - Nephrology 2006 cited by 338

  4. Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury

    Authors: , , , , - Kidney International 2003 cited by 550

  5. Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice

    Authors: , , , , - Journal of the American Society of Nephrology 2005 cited by 279

  6. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

    Authors: , , , , , , , , , - Journal of Clinical Investigation 2001 cited by 460

  7. Relative Incidence of ESRD Versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy: Results From the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) Database

    Authors: , , , , , , , , - American Journal of Kidney Diseases 2011 cited by 206

  8. Global Cardiovascular and Renal Outcomes of Reduced GFR

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ron T. Gansevoort, Philimon Gona, Orlando M. Gutiérrez, Samer Hamidi, Sarah Wulf Hanson, Jonathan Himmelfarb, Simerjot K Jassal, Sun Ha Jee, Vivekanand Jha, Aída Jiménez-Corona, Jost B. Jonas, André Pascal Kengne, Yousef Khader, Young‐Ho Khang, Yun Jin Kim, Barbara E.K. Klein, Ronald Klein, Yoshihiro Kokubo, Dhaval Kolte, Kristine Lee, Andrew S. Levey, Yongmei Li, Paulo A. Lotufo, Hassan Magdy Abd El Razek, Walter Mendoza, Hirohito Metoki, Yejin Mok, Isao Muraki, Paul Muntner, Hiroyuki Noda, Takayoshi Ohkubo, Alberto Ortíz, Norberto Perico, Kevan R. Polkinghorne, Rajaa Al-Radaddi, Giuseppe Remuzzi, Gregory A. Roth, Dietrich Rothenbacher, Michihiro Satoh, Kai‐Uwe Saum, Monika Sawhney, Schoettker, B, Anoop Shankar, Michael Shlipak, Diego Augusto Santos Silva, Hideaki Toyoshima, Kingsley Nnanna Ukwaja, Mitsumasa Umesawa, Vollset, SE, David G. Warnock, Andrea Werdecker, Kazumasa Yamagishi, Yuichiro Yano, Naohiro Yonemoto, Maysaa El Sayed Zaki, Mohsen Naghavi, Mohammad H. Forouzanfar, Christopher J L Murray, Josef Coresh, Theo Vos - 2017 cited by 184

  9. Diagnostic Accuracy of Urine Dipsticks for Detection of Albuminuria in the General Community

    Authors: , , , , , - American Journal of Kidney Diseases 2011 cited by 227

  10. Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Teresa C. Chen, John Chalmers, Mark Woodward, Hisatomi Arima, Vlado Perkovic, Hiroshi Yatsuya, Koji Tamakoshi, Yuanying Li, Yoshihisa Hirakawa, Josef Coresh, Kunihiro Matsushita, Morgan E. Grams, Yingying Sang, Kevan R. Polkinghorne, Steven J. Chadban, Robert C. Atkins, Adeera Levin, Ognjenka Djurdjev, Luxia Zhang, Lisheng Liu, Ming‐Hui Zhao, Fang Wang, Jinwei Wang, Elke Schäeffner, Natalie Ebert, Peter Martus, Adeera Levin, Ognjenka Djurdjev, Mila Tang, Gunnar H. Heine, Insa E. Emrich, Sarah Seiler, Adam M. Zawada, Joseph V. Nally, Sankar D. Navaneethan, Jesse D. Schold, Luxia Zhang, Ming‐Hui Zhao, Fang Wang, Jinwei Wang, Michael G. Shlipak, Mark J. Sarnak, Ronit Katz, Jade S. Hiramoto, Hiroyasu Iso, Kazumasa Yamagishi, Mitsumasa Umesawa, Isao Muraki, Masafumi Fukagawa, Shoichi Maruyama, Takayuki Hamano, Takeshi Hasegawa, Naohiko Fujii, David C. Wheeler, John Emberson, John Townend, Martin Landray, Hermann Brenner, Ben Schöttker, Kai‐Uwe Saum, Dietrich Rothenbacher, Caroline S. Fox, Shih‐Jen Hwang, Anna Köttgen, Florian Kronenberg, Markus P. Schneider, Kai‐Uwe Eckardt, Jamie Green, H. Lester Kirchner, Alex R. Chang and 134 more - American Journal of Kidney Diseases 2018 cited by 94

  11. The Effects of a Low‐Carbohydrate Ketogenic Diet and a Low‐Fat Diet on Mood, Hunger, and Other Self‐Reported Symptoms

    Authors: , , , , - Obesity 2007 cited by 197

  12. A Pathogenic Role for c-Jun Amino-Terminal Kinase Signaling in Renal Fibrosis and Tubular Cell Apoptosis

    Authors: , , , , , , , , - Journal of the American Society of Nephrology 2007 cited by 177

  13. Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)

    Authors: , , , , , , - Diabetes Care 2009 cited by 214

  14. Epidemiology of Diabetic Nephropathy

    Authors: , - Contributions to nephrology 2011 cited by 233

  15. Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy

    Authors: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2011 cited by 169

  16. Prevalence of Kidney Damage in Australian Adults

    Authors: , , , , , , - Journal of the American Society of Nephrology 2003 cited by 678

  17. Risk of Renal Allograft Loss from Recurrent Glomerulonephritis

    Authors: , , , , - New England Journal of Medicine 2002 cited by 550

  18. Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro

    Authors: , , , , , , - Kidney International 1999 cited by 475

  19. COMPOSITION OF INTERSTITIAL CELLULAR INFILTRATE IDENTIFIED BY MONOCLONAL ANTIBODIES IN RENAL BIOPSIES OF REJECTING HUMAN RENAL ALLOGRAFTS

    Authors: , , - Transplantation 1983 cited by 167

  20. Vascular Access and All-Cause Mortality

    Authors: , , , - Journal of the American Society of Nephrology 2004 cited by 431

  21. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

    Authors: , , , , , , , , , , - American Journal of Kidney Diseases 2005 cited by 367

  22. Comparison of the Prevalence and Mortality Risk of CKD in Australia Using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR Estimating Equations: The AusDiab (Australian Diabetes, Obesity and Lifestyle) Study

    Authors: , , , - American Journal of Kidney Diseases 2010 cited by 273

  23. The incidence of biopsy‐proven glomerulonephritis in Australia

    Authors: , , , , , , , , - Nephrology Dialysis Transplantation 2001 cited by 230

  24. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy

    Authors: , , , , , , - Diabetologia 2004 cited by 194